A prognostic score for hodgkin's lymphoma patients at National Cancer Institute, Cairo University / Nagwa Ismail Elsayed ; Supervised Osman Mohamed Mansour , Hanan Ramadan Nassar , Amira Diyaa Darwish
Material type:
- العوامل التكهنيه لمرضى سرطان الغدد الليمفاويه (هودجكن) بالمعهد القومى للأورام [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2014.Na.P (Browse shelf(Opens below)) | Not for loan | 01010110064692000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2014.Na.P (Browse shelf(Opens below)) | 64692.CD | Not for loan | 01020110064692000 |
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology - Medical
Hodgkin{u2019}s lymphoma is a highly curable disease. The study aims to assess the efficacy of the simple scoring system used since 1998 to predict the progression free survival of advanced cases of Hodgkin{u2019}s lymphoma as well as early cases at NCI, Cairo University. Retrospective assessment of patients treated with Hodgkin{u2019}s lymphoma at NCI during the period from January 2007 to December 2010. International prognostic score (IPS), disease free survival (DFS), progression free survival (PFS), and overall survival (OS) were calculated. A total of 191 patients were identified. 98 patients with early stage disease with a median age 24.5 years. The most common histological type encountered in both early and late stage disease was the mixed cellularity (41.8%) , and 51.6% respectively
Issued also as CD
There are no comments on this title.